Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00898391 · ClinicalTrials.gov registry record
Study of DNA in Blood Samples From Patients With Neuroblastoma
A clinical trial, sponsored by Children's Oncology Group.
- Completed
- Registry status
- 329
- Enrollment target
NCT00898391 is a clinical trial that has completed, run by Children's Oncology Group. The registered enrollment target is 329 participants.
The verdict
NCT00898391 has completed, sponsored by Children's Oncology Group.
- COMPLETED
- Registry status
- 329 participants
- Enrollment target
Study Summary
This research trial studies is deoxyribonucleic acid (DNA) in blood samples from patients with neuroblastoma. Studying samples of blood from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. It may also help doctors predict how patients will respond to treatment.
Interventions
- OTHER laboratory biomarker analysis
- GENETIC polymerase chain reaction
- GENETIC DNA analysis
- GENETIC polyacrylamide gel electrophoresis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 329 participants |
| Start Date | 2007-06 |
| Est. Completion | 2016-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00898391
The ClinicalTrials.gov registry entry for NCT00898391 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 329 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Oncology Group, which has 342 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which laboratory biomarker analysis is the first listed.
NCT00898391 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00898391 about?
NCT00898391 is a clinical study titled "Study of DNA in Blood Samples From Patients With Neuroblastoma". This research trial studies is deoxyribonucleic acid (DNA) in blood samples from patients with neuroblastoma. Studying samples of blood from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. It may also help ...
What is the current status of trial NCT00898391?
This trial is currently completed. The enrollment target is 329 participants. The study started on 2007-06. Estimated completion is 2016-05.
What interventions are being tested in trial NCT00898391?
The interventions under investigation include: laboratory biomarker analysis (OTHER), polymerase chain reaction (GENETIC), DNA analysis (GENETIC), polyacrylamide gel electrophoresis (GENETIC).
Who is sponsoring clinical trial NCT00898391?
This trial is sponsored by Children's Oncology Group, which has 342 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.